Gareth Morgan
@DrGarethMorgan1
Followers
4K
Following
934
Media
299
Statuses
2K
Clinician and researcher; committed to improving outcomes of myeloma, amyloid and Waldenstrom's.
NYU Langone, Manhattan, NYC
Joined April 2019
Good job Lou
Happy to share our experience in managing #MGRS in @BrJHaem. #PGNMID remains an area for improvement. Excellent work by Daniel Cancilla and our coauthors. @Bethfaiman @FaizAnwerMD1 @khouri_jack @jamecancerdoc @CleClinicMD #mmsm
https://t.co/N57ht8Nt2t
1
1
7
Great turnout from NYU CBC
0
0
4
Pleased for a positive response for Blenrep sadly more work for our pharmacy to get it on the formulary
gsk.com
Blenrep is the only anti-BCMA accessible in the community setting where 70% of patients receive care.
0
0
3
Niels work is highly interesting and highlights how the concepts developed by Darwin in the mid 1800 are relevant to cancer development in 2025
Session 4 is underway at #iwHRMM25, and Niels Weinhold of @HDMyeloma discusses high-risk features of bone marrow-independent disease #MultipleMyeloma #MMsm #Myeloma
5
3
14
Caught in the act of public speaking thx for the opportunity and to the organisers
Kicking off session 3 at #iwHRMM25 with @DrGarethMorgan1 of @nyulangone, who is discussing the transcriptional drivers of aggressive clinical behavior. 🩸🎤 #MMSM #MultipleMyeloma #Myeloma #HemOnc
0
2
11
Well done Brian
#Myeloma Paper of the Day: Diagnostic sequencing identifies high-risk markers + resistance mechanisms (Cereblon pathway alterations in 24.3% of IMiD-treated pts, del 4p (CD38) in pts post-anti-CD38, BCMA deletions & mutations pts txd w/ anti-BCMA: https://t.co/dWPLkdGZRc.
#mmsm
0
1
6
Stay informed with the International Myeloma Working Group (IMWG) 2025 Consensus Guidelines on high-risk chromosomal abnormalities in multiple #myeloma. #mmsm @FaithEDavies1
https://t.co/vf3BvtuSvV
1
4
16
This is a really important change that will enhance progress for high-risk myeloma patients
New publication 📝 The IMS-IMWG recommended high-risk MM definition, published in @JCO_ASCO, is based on new evidence from molecular and genomic assays, updated clinical data, and risk stratification tools for MM. Learn more: https://t.co/eHpkjvJTHu
#mmsm #myeloma #MedNews
0
1
4
Sad to see him go
As one of the principal academic beneficiaries of Dr. Brian Durie’s mentorship, guidance, and kindness I am heartbroken to hear of his passing. His contributions to myeloma and oncology are without parallel. Charismatic, brilliant, dedicated, Dr. Durie has had a huge impact on
0
0
7
This is great fun Debra
0
0
5
Met up with this young man Chris, who paced us around the MMRF 5k - thx bud
2
2
27
Fascinated by the emerging field of spatial transcriptomics in the bone marrow. Happy to share our new editorial, co-authored with Niels Weinhold: Unlocking myeloma’s spatial world at the micrometer scale. https://t.co/UF3AEcjWjT I also recommend the new paper by Yip et al. 👍
0
5
21
Genomic classification of MM precursor conditions can improve their clinical management and deliver better patient outcomes
Just out in the Journal of Clinical Oncology! @JCO_ASCO A paradigm changing paper on MGUS and Smoldering Myeloma @FrancescoMaura4 And it’s Open Access!! https://t.co/XgIW0EyrC9 KEY FINDINGS: 1) We identify for the first time myeloma defining genomic events to differentiate
1
2
16
These data make the case for the IMS consensus high-risk definitions and capture what we have known for many years from gene expression risk assessments
#Myeloma Paper of the Day: AURIGA subgroup analysis finds dara/len maint in NDMM -> higher MRD (10-5) conversion @ 12 mos in original high-risk (31.8 vs 6.7%), revised (43.8 vs 13.3%) & modified IMS 2024 (41.2 vs 0%) & ultra-high-risk (54.5 vs 0%): https://t.co/0AEbUmNJZ2.
#mmsm
0
3
9
At #IMS25, we spoke with @DrGarethMorgan1 of @nyulangone, who provided practical advice to support earlier recognition and diagnosis of #amyloidosis.🩸 Click here to watch: 👉 https://t.co/jipG2xwATY 👈 @Myeloma_Society #HemOnc
vjhemonc.com
Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone Health, New York City, NY, gives advice to support earlier recognition and diagnosis of amyloidosis. Prof. Morgan emphasizes the importance of...
2
3
8